Other
HPV genotyping
HPV genotyping is an intervention with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
2(67%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Terminated1
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
terminated133%
active_not_recruiting133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruiting
Follow-up of Cell Changes in the Cervix
NCT05709730
recruitingnot_applicable
HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic Acid
NCT05385406
terminatednot_applicable
Quantitative HPV Genotyping in Screening of Anal Intraepithelial Neoplasia in HIV-positive Patients
NCT03742375
Clinical Trials (3)
Showing 3 of 3 trials
NCT05709730
Follow-up of Cell Changes in the Cervix
NCT05385406Not Applicable
HPV Screening With Triage by HPV Genotyping Versus Visual Inspection With Acetic Acid
NCT03742375Not Applicable
Quantitative HPV Genotyping in Screening of Anal Intraepithelial Neoplasia in HIV-positive Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3